首页> Arthritis research & therapy> CD14<sup>bright</sup>CD16+ intermediate monocytes are induced by interleukin-10 and positively correlate with disease activity in rheumatoid arthritis.

CD14<sup>bright</sup>CD16+ intermediate monocytes are induced by interleukin-10 and positively correlate with disease activity in rheumatoid arthritis.

导出 OA

翻译打印收藏纠错

第一作者： Masako,Tsukamoto

第一单位： Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.

作者： Masako,Tsukamoto ^[1] ; Noriyuki,Seta ^[2] ; Keiko,Yoshimoto ^[3] ; Katsuya,Suzuki ^[1] ; Kunihiro,Yamaoka ^[1] ; Tsutomu,Takeuchi ^[4]

作者单位： Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. ^[1] Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.;Department of Internal Medicine, Tokyo Dental College Ichikawa General Hospital, 5-11-13 Sugano, Ichikawa, Chiba, 272-8513, Japan. ^[2] Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.;Clinical and Translational Research Center, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. ^[3] Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. tsutake@z5.keio.jp. ^[4]

关键词 CD16 Interleukin-10 Monocytes Rheumatoid Arthritis